4.5 Article

Building a tissue-based molecular diagnostic system in heart transplant rejection: The heart Molecular Microscope Diagnostic (MMDx) System

期刊

JOURNAL OF HEART AND LUNG TRANSPLANTATION
卷 36, 期 11, 页码 1192-1200

出版社

ELSEVIER SCIENCE INC
DOI: 10.1016/j.healun.2017.05.029

关键词

antibody-mediated rejection; T cell-mediated rejection; archetype analysis; endomyocardial biopsy; rejection-associated transcripts; microarrays

资金

  1. Novartis Pharma AG
  2. Genome Canada
  3. Canada Foundation for Innovation
  4. University Of Alberta Hospital Foundation
  5. Roche Molecular Systems
  6. Hoffmann-La Roche Canada Ltd
  7. Alberta Ministry of Advanced Education and Technology
  8. Roche Organ Transplant Research Foundation
  9. Astellas

向作者/读者索取更多资源

BACKGROUND: The emergence of molecular systems offers opportunities for improving the assessment of rejection in heart transplant biopsy specimens. The present study developed a microarray-based system for assessing heart transplant endomyocardial biopsy (EMB) specimens. METHODS: We analyzed 331 protocol or for-cause EMB specimens from 221 subjects in 3 centers (Edmonton, Bologna, and Paris). Unsupervised principal component analysis (PCA) and archetype analysis used rejection-associated transcripts (RATs) shown in kidney transplants to be associated with antibody mediated rejection (ABMR) or T cell-mediated rejection (TCMR), or both. To compare EMB specimens to kidney biopsy specimens, rejection status in both was simplified to TCMR, ABMR, or no rejection. RESULTS: The pattern of RAT expression was similar in EMB and kidney specimens, permitting use of RATs to assign scores and group (cluster) membership to each EMB, independent of histology. Three clusters emerged in EMB specimens, similar to kidney specimens: TCMR, ABMR, and no rejection. This permitted each EMB specimen to be given 3 scores and assigned to 1 cluster by its highest score. There was significant agreement between molecular phenotype-archetype scores or clusters-and both histologic diagnoses and donor-specific antibody. Area under curve estimates for predicting histologic TCMR, ABMR, and no rejection by molecular assessment were lower in EMB specimens than in kidney specimens, reflecting more uncertainty in EMB specimens, particularly in histologic diagnosis of TCMR. CONCLUSIONS: Rejection-associated transcripts can be used to estimate the probability of TCMR and ABMR in heart transplant specimens, providing a new dimension to improve the accuracy of diagnoses and an independent system for recalibrating the histology guidelines. (C) 2017 International Society for Heart and Lung Transplantation. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据